ArticleCommunications biology2021

Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection.

Thomas L Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.